The European CRT Survey: 1 year (9–15 months) follow‐up results

The European CRT Survey is a joint initiative of the Heart Failure Association (HFA) and the European Heart Rhythm Association (EHRA) of the European Society of Cardiology evaluating the contemporary implantation practice of cardiac resynchronization therapy (CRT) in Europe.

[1]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[2]  Panos Vardas,et al.  The EHRA White Book. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[4]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[5]  K. Dickstein,et al.  The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[6]  M. Brignole,et al.  Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. , 2011, European heart journal.

[7]  K. Dickstein,et al.  The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades , 2011, European journal of heart failure.

[8]  Finn Gustafsson,et al.  2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .

[9]  J. Sturdivant.  Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy , 2011 .

[10]  John L Sapp,et al.  Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.

[11]  J Taylor,et al.  Focused update of the ESC Guidelines on device therapy in heart failure. , 2010, European heart journal.

[12]  J. Cleland,et al.  Should we be trying to define responders to cardiac resynchronization therapy? , 2010, JACC. Cardiovascular imaging.

[13]  P. Vardas,et al.  Tracing the European course of cardiac resynchronization therapy from 2006 to 2008. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[14]  C. Granger,et al.  Clinical trials and registries in cardiovascular disease: competitive or complementary? , 2010, European heart journal.

[15]  H. Bueno,et al.  The role of cardiac registries in evidence-based medicine. , 2010, European heart journal.

[16]  S. Kaul,et al.  Trial and error. How to avoid commonly encountered limitations of published clinical trials. , 2010, Journal of the American College of Cardiology.

[17]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[18]  K. Dickstein,et al.  Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008 , 2009, European journal of heart failure.

[19]  K. Dickstein,et al.  The European cardiac resynchronization therapy survey. , 2009, European heart journal.

[20]  S. Committee.  European cardiac resynchronization therapy survey: rationale and design , 2009, European journal of heart failure.

[21]  J. Daubert,et al.  Cardiac resynchronization therapy: are modern myths preventing appropriate use? , 2009, Journal of the American College of Cardiology.

[22]  S. A. Christman,et al.  Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure: is a goal of 100% biventricular pacing necessary? , 2009, Journal of the American College of Cardiology.

[23]  N. Freemantle,et al.  The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial , 2008, European heart journal.

[24]  Claudia Stöllberger,et al.  Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.

[25]  Stefano Ghio,et al.  Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. , 2008, Journal of the American College of Cardiology.

[26]  Michael Böhm,et al.  Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 , 2008, European journal of heart failure.

[27]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.

[28]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.

[29]  M. Metra,et al.  Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation , 2008, European heart journal.

[30]  J. Daubert,et al.  Baseline characteristics of patients randomized in The Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction (REVERSE) study. , 2008, Congestive heart failure.

[31]  J. Daubert,et al.  Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study , 2007, Heart.

[32]  J. Daubert,et al.  Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. , 2007, European heart journal.

[33]  J. Ottervanger,et al.  Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. , 2007, The American journal of cardiology.

[34]  J. Blankensteijn,et al.  Impact of study design on outcome after endovascular abdominal aortic aneurysm repair. A comparison between the randomized controlled DREAM-trial and the observational EUROSTAR-registry. , 2007, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[35]  M. Metra,et al.  Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy. , 2007, The American journal of cardiology.

[36]  J. Daubert,et al.  The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. , 2006, European heart journal.

[37]  Sanjay Kaul,et al.  Trial and error. How to avoid commonly encountered limitations of published clinical trials. , 2010, Journal of the American College of Cardiology.

[38]  Catherine Klersy,et al.  Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. , 2006, Journal of the American College of Cardiology.

[39]  Nick Freemantle,et al.  Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. , 2006, European heart journal.

[40]  Karl Swedberg,et al.  Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. , 2005, European heart journal.

[41]  A. Greenspon,et al.  Cardiac resynchronization therapy in patients with right bundle branch block: analysis of pooled data from the MIRACLE and Contak CD trials. , 2005, Heart rhythm.

[42]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[43]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[44]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[45]  Milton Packer,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[46]  D. Delurgio,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[47]  Thomas Lavergne,et al.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay , 2001 .